The abstract is read at the publisher; the summary is JClub's.
Between January 2013 and May 2021, 9.90% (112,411) of 1,135,194 germline single-nucleotide variant submissions in ClinVar had been reclassified by May 2024.
- Why it matters: Variant reclassification over time complicates interpreting genomic findings for life-impacting decisions, yet rates and patterns are not well quantified across the full ClinVar submission landscape.
- What they did: Monthly archived ClinVar Reference record files were analyzed to track classification changes across time for each Submitted record identifier, comparing ACMG/AMP and other category directions.
- The result: Likely pathogenic had the highest ACMG/AMP reclassification rate (15.25%) and Benign the lowest (1.59%), while only 10.56% of variants of uncertain significance were reclassified despite 48.78% of initial classifications.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.